CLINICAL_TRIALS trial_result · 2021-08-24

Clinical Trial Update: Safety and Efficacy of Abatacept in IgG4-Related Disease [Phase 2]

Phase 2 trial assessing safety and efficacy of abatacept in IgG4-related disease has completed with posted results in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Massachusetts General Hospital | Conditions: IgG4-related Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-08-24